在类风湿性肺结核病中使用利图西马布治疗:一个病例报告
Makhlouf Yasmine1, Maatallah Kaouther1, Kaffel Dhia1
1Department of Rheumatology, Mohammed Kassab National Institute of Orthopedics, Ksar Said, Mannouba 2010, Tunisia.
Current drug safety
|May 31, 2023
概括
利图西马布治疗稳定了患有类风湿性肺炎和类风湿性关节炎的患者的卡普兰结节. 需要进一步的试验来确认它对这种罕见疾病的有效性.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 卡普兰综合征或类风湿性肺炎症 (RP) 是一种罕见的疾病,它将肺炎和类风湿性关节炎 (RA) 联系在一起.
- 评估Rituximab对RP患者肺结核病的影响并不常见.
研究的目的:
- 评估Rituximab在患有同时存在类风湿性关节炎的患者肺结核病的作用.
- 评估Rituximab对RA症状和卡普兰综合征肺部变化的影响.
主要方法:
- 一名67岁的男性患者患有肺结核病和RA,接受了 leflunomide 治疗,随后因缺乏反应而接受了 Rituximab.
- 临床评估关节疼痛和胀,以及对卡普兰结节的胸部计算机断层扫描 (CT),用于监测治疗疗效.
主要成果:
- 患者在类风湿性关节炎症状中显著改善,包括疼痛和胀的减少.
- 胸部CT显示了卡普兰结节的稳定,表明在Rituximab治疗期间肺病没有进展.
结论:
- 利图西马布可能为卡普兰综合征的类风湿关节炎组成部分提供临床益处.
- 在肺炎症中使用Rituximab似乎不会改变肺结节的演变.
- 需要进行进一步的临床试验,以确定类风湿性肺炎症的最终治疗指南.
相关概念视频
Pneumothorax-II
222
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
222
Rheumatic Heart Disease III: Medical Management
22
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
Pneumonia IV: Management
403
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
403
Pulmonary Tuberculosis V
219
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
219
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Rheumatic Heart Disease I: Introduction
21
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
21


